Hidden clues in prostate cancer – Lessons learned from clinical and pre-clinical approaches on diagnosis and risk stratification.

The heterogeneity of prostate cancer is evident at clinical, morphological and molecular levels. To aid clinical decision making, a three-tiered system for risk stratification is used to designate low-, intermediate-, and high-risk of disease progression.